Respiratory Complication: Clinical Trials

2 trials for Respiratory Complication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow Respiratory Complication: new trials by email Literature Review of Respiratory Complication trials Research Report on Respiratory Complication

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Vapendavir, Placebo - COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection
Phase 2CompletedAltesa Biosciences, Inc.522023-11-202025-09-30
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
Pemziviptadil (PB1046), Low Dose (10 mg) Control - Acute Respiratory Distress Syndrome, Coronavirus
Phase 2TerminatedPhaseBio Pharmaceuticals Inc.542020-07-152020-12-11

Narrower conditions

COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Common Cold (1)  ·  Coronavirus Infections (1)  ·  Cytokine Release Syndrome (1)  ·  Dyspnea (1)  ·  Emphysema (1)  ·  Enterovirus Infections (1)  ·  Heart Failure (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Myocardial Infarction (1)  ·  Pneumonia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Chronic Disease (1)  ·  Coronaviridae Infections (1)  ·  Disease Attributes (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Ischemia (1)  ·  Lung Diseases (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Nidovirales Infections (1)  ·  Picornaviridae Infections (1)

Interventions

VIP-ELP fusion molecule PB1046 (1)

Sponsors

Altesa Biosciences, Inc. (1)  ·  PhaseBio Pharmaceuticals Inc. (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Onn Min Kon, MD (1)